Kaye JA - Search Results

1

The ageing systemic milieu negatively regulates neurogenesis and cognitive function.

Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. Villeda SA, et al. Among authors: kaye ja. Nature. 2011 Aug 31;477(7362):90-4. doi: 10.1038/nature10357. Nature. 2011. PMID: 21886162 Free PMC article.

2

Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain.

Quinn J, Suh J, Moore MM, Kaye J, Frei B. Quinn J, et al. J Alzheimers Dis. 2003 Aug;5(4):309-13. doi: 10.3233/jad-2003-5406. J Alzheimers Dis. 2003. PMID: 14624026 Clinical Trial.

3

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW Jr, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. Clark CM, et al. Arch Neurol. 2003 Dec;60(12):1696-702. doi: 10.1001/archneur.60.12.1696. Arch Neurol. 2003. PMID: 14676043

4

Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.

Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Quinn JF, et al. Among authors: kaye ja. J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110. J Alzheimers Dis. 2004. PMID: 15004331

5

Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.

Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA. Adair JC, et al. Among authors: kaye ja. Stroke. 2004 Jun;35(6):e159-62. doi: 10.1161/01.STR.0000127420.10990.76. Epub 2004 Apr 22. Stroke. 2004. PMID: 15105518

6

apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice.

Robertson J, Curley J, Kaye J, Quinn J, Pfankuch T, Raber J. Robertson J, et al. Neurobiol Aging. 2005 May;26(5):637-43. doi: 10.1016/j.neurobiolaging.2004.06.003. Neurobiol Aging. 2005. PMID: 15708438

7

Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.

Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ. Vuletic S, et al. Among authors: kaye ja. J Neurosci Res. 2005 May 1;80(3):406-13. doi: 10.1002/jnr.20458. J Neurosci Res. 2005. PMID: 15795933

8

Safety and acceptability of the research lumbar puncture.

Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D. Peskind ER, et al. Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):220-5. doi: 10.1097/01.wad.0000194014.43575.fd. Alzheimer Dis Assoc Disord. 2005. PMID: 16327349 Clinical Trial.

9

Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease.

Montine TJ, Quinn JF, Montine KS, Kaye JA, Breitner JC. Montine TJ, et al. Among authors: kaye ja. J Alzheimers Dis. 2005 Mar;8(4):359-67. doi: 10.3233/jad-2005-8405. J Alzheimers Dis. 2005. PMID: 16556967 Review.

10

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.

Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR. Peskind ER, et al. Among authors: kaye ja. Arch Neurol. 2006 Jul;63(7):936-9. doi: 10.1001/archneur.63.7.936. Arch Neurol. 2006. PMID: 16831961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page